Argatska Antoaneta, Nonchev Boyan, Orbetzova Maria, Pehlivanov Blagovest
a Department of Endocrinology and Metabolic Diseases , Medical University , Plovdiv , Bulgaria and.
b Department of Obstetrics and Gynecology , Medical University , Plovdiv , Bulgaria.
Gynecol Endocrinol. 2016;32(5):379-82. doi: 10.3109/09513590.2015.1124261. Epub 2015 Dec 15.
Autoimmune thyroiditis (AIT) is a predisposing factor for developing postpartum thyroid dysfunction (PPTD).
To study the characteristics of PPTD in women with AIT.
Thirty-eight women with pre-existing AIT were included in the study. Thyroid-stimulating hormone, free triiodthyronine, free thyroxine, thyroid peroxidase antibodies, thyroglobulin antibodies were measured and ultrasound evaluation of the thyroid gland was performed in the first trimester of pregnancy and during the first year following delivery.
Thyroid dysfunction was recognized in 68.4% of the patients - 28.9% presented with hypothyroidism and 39.5 % with thyrotoxicosis. The immunological and morphological parameters did not differ between euthyroid women and those with thyroid dysfunction. At the end of the postpartum period restoration of euthyroid state (being on the treatment before pregnancy) was observed in 15.4% of patients with PPTD, while 84.6% required increase of the levothyroxine dose. The analysis found a significantly lower volume of the thyroid gland, shorter duration of the disease, a lower dose of levothyroxine before and during gestation in patients with impaired thyroid function at the end of the postpartum period.
The risk of PPTD in women with AIT predating pregnancy is higher among women with preserved thyroid functional capacity motivating a thorough assessment of thyroid hormone levels and close follow-up of those women during the postpartum period.
自身免疫性甲状腺炎(AIT)是产后甲状腺功能障碍(PPTD)发生的一个诱发因素。
研究患有AIT的女性中PPTD的特征。
38名患有既往AIT的女性被纳入研究。在妊娠早期和产后第一年测量促甲状腺激素、游离三碘甲状腺原氨酸、游离甲状腺素、甲状腺过氧化物酶抗体、甲状腺球蛋白抗体,并对甲状腺进行超声评估。
68.4%的患者出现甲状腺功能障碍——28.9%表现为甲状腺功能减退,39.5%表现为甲状腺毒症。甲状腺功能正常的女性和甲状腺功能障碍的女性之间的免疫学和形态学参数没有差异。在产后期末,15.4%的PPTD患者甲状腺功能恢复正常(妊娠前接受治疗),而84.6%的患者需要增加左甲状腺素剂量。分析发现,产后期末甲状腺功能受损的患者甲状腺体积明显较小,病程较短,妊娠前和妊娠期左甲状腺素剂量较低。
妊娠前患有AIT的女性发生PPTD的风险在甲状腺功能保持正常的女性中更高,这促使对这些女性的甲状腺激素水平进行全面评估,并在产后期间对其进行密切随访。